|
| Status |
Public on Jul 18, 2013 |
| Title |
Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease |
| Organism |
Mus musculus |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
23872847 |
| Submission date |
Jul 17, 2013 |
| Last update date |
May 15, 2019 |
| Contact name |
Christopher Ng |
| Organization name |
Massachusetts Institute of Technology
|
| Street address |
77 Massachusetts Ave.
|
| City |
Cambridge |
| State/province |
Massachusetts |
| ZIP/Postal code |
02139 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL11002 |
Illumina Genome Analyzer IIx (Mus musculus) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
| Samples (32)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE48960 |
Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease (ChIP-seq) |
| GSE48962 |
Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease (RNA-seq) |
|
| Relations |
| BioProject |
PRJNA212427 |
Less...
More...